Enovis Corp (ENOV) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Enovis Corporation (NYSE:ENOV) Could Be Riskier Than It Looks
Simply Wall StFeb 22 07:16 ET
Earnings Preview: Enovis Corp to Report Financial Results on February 26
Moomoo NewsFeb 20 20:00 ET
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
GlobeNewswireJan 29 07:00 ET
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
Seeking AlphaJan 22 11:44 ET
Enovis Appoints Davide Visentin as President of International Surgical, Effective March 1, 2025
Quiver QuantitativeJan 17 06:11 ET
Enovis Announces Leadership Change to International Surgical Business
GlobeNewswireJan 17 06:00 ET

Comments

Moomoo AI

Feb 26, 2024 07:55

The company's use of debt is seen as risky due to its EBIT loss and the liabilities it has. The balance sheet is not considered strong, but it could improve over time. The stock is considered quite risky.

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

1

Moomoo AI

Feb 25, 2024 17:55

Needham analysts predict Enovis's new products, orthopedic market strength, and the Lima acquisition will exceed 2024 consensus. They also foresee Paragon 28 returning to roughly 20% revenue growth in 2024 due to new bunion-focused products, supply chain enhancements, and sales force growth.

Needham Sees Orthopedics Market Slowing; Favors Enovis, Paragon 28

Moomoo AI

Dec 5, 2023 05:10

Enovis CEO Matt Trerotola praised Shirley, Vogt, and Ross for their roles in the company's growth. He highlighted Shirley's influence on Enovis's transformation to a medtech firm, Vogt's contribution to the U.S. surgical business growth, and Ross's work in ensuring sustained growth in the P&R segment.

Press Release: Enovis Announces Business Segment Leadership Transition Plan

Moomoo AI

Nov 30, 2023 07:01

Enovis' falling revenue and absent profits might have led to a drop in share price. Viewing the total shareholder return and recent share price rise, the company may suggest investment potential if it shows sustainable long term growth.

Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Nov 3, 2023 09:26

Enovis's rise in liabilities and recent EBIT loss spark concerns about its debt use and future profitability. With a negative free cash flow of US$106m over the past year, the company's financial risk is evident. Balance sheet situation calls for caution due to dubious circumstances.

Would Enovis (NYSE:ENOV) Be Better Off With Less Debt?

ENOV Enovis Corp

Trade Overview

Capital Trend

News

Comments

Trending Stocks